Additionally, cell viability assays (CCK-8) and colony formation assays demonstrated that PROX1 inhibition in CRC cells significantly decreased the viability and colony-forming abilities of the cells (p < 0.01; Figure 2B, 2C). This evidence concerns the gene PROX1 and colorectal carcinoma.